In Case You Missed It: Specialty Pharmacy Times Week in Review

March 22, 2015

A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.

A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.

Nanoparticles May Increase Effectiveness of Lung Cancer Drugs

Treatment can selectively drop medication at the site of tumors.

New Approach Needed to Finance Expensive Specialty Drugs

Report finds suppliers could spur investment through methods that include equipment leases or supplier-financed credit.

FDA Accepts Combination Hepatitis C Treatment Application for Review

Bristol-Myers Squibb is also clinically testing the potential of daclatasvir-based regimens in patients co-infected with HIV.

Preventing Early Menopause in Breast Cancer Patients

Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.

FDA Approves Treatment for Bile Acid Synthesis Disorders

First treatment option approved for rare condition.

Improper Temperature Control: A Global Problem

Globally, from Tunisia to the United States, underuse of digital temperature loggers leads to loss of product potency and efficacy for patients.

Gene Therapy Could Generate Powerful Hemophilia Treatment

Process produces protein with high blood clotting ability.

Herpes Drug May Lower HIV Levels

Study finds HIV-1 viral loads decreased following treatment with Valtrex.

Antibody Therapy Shows Promise in Halting Psoriasis

Experimental treatment blocks signaling protein.

Antisense Technology Shows Promising Results in Crohn’s Disease Treatment

Significant number of patients taking once daily oral therapy achieve clinical remission during a recent trial.